MEMBRANOUS NEPHROPATHY

Clinical trials for MEMBRANOUS NEPHROPATHY explained in plain language.

Never miss a new study

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

Sign up with your email to follow new studies for MEMBRANOUS NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 5 Not yet finished but already full! 1 Completed 3 Terminated 2

New drug shows promise for tough kidney diseases

Disease control Ongoing

This study tests a new drug called povetacicept in adults with certain autoimmune kidney diseases, including lupus nephritis and IgA nephropathy. The goal is to see if the drug is safe and can help control the disease. Participants receive the drug every 4 weeks for at least 6 mo…

Matched conditions: MEMBRANOUS NEPHROPATHY

Phase: PHASE1, PHASE2 • Sponsor: Alpine Immune Sciences, Inc. • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

MEMBRANOUS NEPHROPATHY

Get alerted when new MEMBRANOUS NEPHROPATHY trials appear

New drug shows promise for tough kidney diseases